PPARG and metabolic dysfunction-associated steatotic liver disease: In agreement with these studies, we recently reported that both HFD and palmitic acid alter global and Pparγ promoter DNA methylation leading to a significant induction of PPARγ expression and enhanced lipid retention in the liver, which lead to NAFLD development [38].